Patients are increasingly being encouraged and supported to access and control their own medical and genomic data. We argue that well-established and transparent raw genomic data retention and returning policies are imperative to enable patients to practice their rights to access and control raw data.
Keywords: access rights; genomic data; patients; raw data.
Copyright © 2017 Elsevier Ltd. All rights reserved.